ATE538814T1 - Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien - Google Patents

Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien

Info

Publication number
ATE538814T1
ATE538814T1 AT06717499T AT06717499T ATE538814T1 AT E538814 T1 ATE538814 T1 AT E538814T1 AT 06717499 T AT06717499 T AT 06717499T AT 06717499 T AT06717499 T AT 06717499T AT E538814 T1 ATE538814 T1 AT E538814T1
Authority
AT
Austria
Prior art keywords
surfactant
prevention
treatment
dosage scheme
lung dysplasia
Prior art date
Application number
AT06717499T
Other languages
English (en)
Inventor
Anthony Killian
Christopher Schaber
Robert Segal
Carlos Guardia
Original Assignee
Discovery Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36169079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE538814(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Discovery Lab Inc filed Critical Discovery Lab Inc
Application granted granted Critical
Publication of ATE538814T1 publication Critical patent/ATE538814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT06717499T 2005-01-06 2006-01-06 Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien ATE538814T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64180505P 2005-01-06 2005-01-06
PCT/US2006/000308 WO2006074296A1 (en) 2005-01-06 2006-01-06 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Publications (1)

Publication Number Publication Date
ATE538814T1 true ATE538814T1 (de) 2012-01-15

Family

ID=36169079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06717499T ATE538814T1 (de) 2005-01-06 2006-01-06 Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien

Country Status (13)

Country Link
US (1) US7541331B2 (de)
EP (2) EP2298349A1 (de)
JP (2) JP2008526868A (de)
AT (1) ATE538814T1 (de)
AU (1) AU2006203978B2 (de)
CA (1) CA2593758A1 (de)
CY (1) CY1112769T1 (de)
DK (1) DK1841458T3 (de)
ES (1) ES2380046T3 (de)
PL (1) PL1841458T3 (de)
PT (1) PT1841458E (de)
SI (1) SI1841458T1 (de)
WO (1) WO2006074296A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
EP2063903A1 (de) * 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Lungentensidformulierungen und verfahren zur förderung von schleimbeseitigung
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
US7951781B2 (en) * 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
AU2014204490B2 (en) * 2008-01-31 2016-05-12 Vanderbilt University Therapeutic treatment for lung condtions
JP5623916B2 (ja) 2008-01-31 2014-11-12 バンダービルト・ユニバーシティＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
KR20170005155A (ko) * 2008-01-31 2017-01-11 반더빌트유니버시티 폐의 용태에 따른 치료 방법
US9044392B2 (en) * 2010-03-19 2015-06-02 Wisconsin Alumni Research Foundation Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
US20190175502A1 (en) * 2015-10-20 2019-06-13 Indiana University Research & Technology Corporation Methods and compositions for treating lung disease of prematurity
CA3043792A1 (en) * 2016-12-22 2018-06-28 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd
KR102781186B1 (ko) * 2018-04-23 2025-03-17 키에시 파르마슈티시 엣스. 피. 에이. Bpd의 예방을 위한 폐 계면활성제 및 스테로이드를 포함하는 치료학적 조합물
KR102173673B1 (ko) * 2018-05-04 2020-11-03 사회복지법인 삼성생명공익재단 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법
US12440471B2 (en) * 2021-07-30 2025-10-14 Ayuvis Research, Inc. Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US502495A (en) 1893-08-01 klijsel
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4918161A (en) 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
IT1203873B (it) 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
ATE163013T1 (de) 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6013619A (en) 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5238920A (en) 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
US5272252A (en) 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
ES2192190T3 (es) 1992-04-10 2003-10-01 Abbott Lab Fragmentos proteicos tensioactivos pulmonares.
US5302481A (en) 1993-06-07 1994-04-12 Xerox Corporation Toner compositions with negative charge enhancing complexes
DK0733645T3 (da) 1993-12-08 2003-07-14 Mitsubishi Pharma Corp Syntetisk peptid, lungeoverfladeaktivt stof indeholdende dette og præparat mod respiratory distress syndrome
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5863563A (en) * 1994-10-20 1999-01-26 Alphagene Inc. Treatment of pulmonary conditions associated with insufficient secretion of surfactant
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US6884777B1 (en) 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
JP2004305006A (ja) * 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
WO2005115520A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
WO2006026237A1 (en) 2004-05-20 2006-03-09 Discovery Laboratories, Inc. Methods, systems and devices for noninvasive pulmonary delivery

Also Published As

Publication number Publication date
AU2006203978A1 (en) 2006-07-13
EP1841458B1 (de) 2011-12-28
PL1841458T3 (pl) 2012-05-31
US20060194728A1 (en) 2006-08-31
SI1841458T1 (sl) 2012-04-30
AU2006203978B2 (en) 2011-11-03
EP2298349A1 (de) 2011-03-23
DK1841458T3 (da) 2012-04-23
US7541331B2 (en) 2009-06-02
JP2013177422A (ja) 2013-09-09
ES2380046T3 (es) 2012-05-08
CA2593758A1 (en) 2006-07-13
EP1841458A1 (de) 2007-10-10
HK1109078A1 (en) 2008-05-30
EP1841458B9 (de) 2012-12-12
PT1841458E (pt) 2012-04-10
WO2006074296A1 (en) 2006-07-13
CY1112769T1 (el) 2016-02-10
JP2008526868A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
ATE538814T1 (de) Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
DE602005017636D1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
DE602005001929D1 (de) Sulfonamidderivate zur behandlung von krankheiten
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA201000098A1 (ru) Производные хиназолинамида
EA201691759A1 (ru) Композиции и способы лечения легочной гипертензии
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
CY1118947T1 (el) Ασυμμετρες ουριες και ιατρικες χρησεις αυτων
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
EA201100872A1 (ru) Производные хиназолинамида
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
CY1118583T1 (el) Σταθερες δοσολογικες μορφες ανθελονοσιακων σπιρο και δισπιρο 1,2,4-τριοξολανιων
NO20076405L (no) Anvendelse av 24-nor-UDCA
EA200901474A1 (ru) Соли [4-(6-фтор-7-метиламино-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины в различных кристаллических формах и фармацевтические композиции на их основе
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE257384T1 (de) Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
FR2884724B1 (fr) Appareil d'aide a la reanimation d'un patient victime d'un arret cardiaque